Clinical Trials

 

Development of Fecal Scoring for the Management of Fecal Impaction With Regards to Lower Urinary Tract Dysfunction

Intervention Type: Drug
Study Type: Observational
Sponsors: Seoul National University Hospital
Participants: 187
Abstract
The role of bowel bladder disorder, or BBD, has been highlighted as a major player in vesicoureteral reflux and urinary tract infection (UTI). However, the diagnosis of BBD are still conceptual and subjective, because of the diagnosis of constipation, main pathophysiology in BBD has not been established well.
* Consult with your doctor before enrolling in clinical trials.
Facilities
Seoul National University Hospital - Recruiting
Seoul, Republic of Korea
Contacts
Backup
Louis Kim, B.S.
kim.hyunkyu11@gmail.com
+82-10-4201-0636
Primary
Kwanjin Park, M.D. Ph.D
urodori@naver.com
+82-2-2072-0695
Eligibilities
Sex: All
Minimum Age: 5
Maximum Age: 13
Healthy Volunteers: No
Inclusion Criteria:
- Patients with having both significant Lowery Urinary Tract Dysfunction history suggestive of constipation (more than two positive criteria in ROME 4).
- Parental recalling of hard stool (Bristol stool scale of 6 or 7).
- Parental impression of constipation.
Exclusion Criteria:
- Those without Lower Urinary Tract Dysfunction or constipation.

View Article From Source